🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Monster Stock Market Predictions: Super Edition For The Week

Published 06/14/2021, 12:03 AM
Updated 09/20/2023, 06:34 AM
US500
-
JP225
-
C
-
SPY
-
AAPL
-
BIIB
-
ICE
-
DX
-
ACAD
-
DJT
-
DE10YT=RR
-
US10YT=X
-
TLT
-
XLF
-
DE10US10=RR
-

Interest rates fell sharply at the end of the week, and while the immediate knee-jerk reaction would be that this was because of the CPI report. There was actually much more going on here.

Rates have been falling all over the world, from Japan to Germany, even China. This tells us that falling rates are not unique to the US and that, in reality, rates are falling in the US because foreign buyers are picking up US bonds as they offer much higher and more attractive yields.

It could even help explain why the US dollar has suddenly spiked in recent days, as foreign bond buyers sell their local currency, buy dollars, and then buy US debt. It is probably why the dollar continues to rally back to 91 on the dollar index.

DXY Daily Chart

US/German Spread

The US/German 10-year spread has remained fairly constant, around 1.75% since the middle of May, despite the US rate falling by 20 bps to 1.45%. That is due to the German 10-year falling to -27 bps, from -7bps.

Of course, it probably doesn’t help that the ECB announced that it would continue to buy bonds at an accelerated pace on Thursday.

US/German Spread Daily Chart

US 10 Vs. The Nikkei

The 10-Year may even be telling us what happens next to equity markets around the globe. The US 10-year and the Japanese Nikkei have a breathtaking correlation. If the US 10-year falls from here as it chases global rates lower than it seems, the Japanese Nikkei is to head lower too.

US 10 Vs. The Nikkei Chart

Nikkei To S&P 500

For the first time, the Nikkei and the S&P 500 are diverging by quite a bit.

Nikkei Vs. SPX Chart

S&P 500 To Treasuries

Meanwhile, the SPDR® S&P 500 (NYSE:SPY) to iShares 20+ Year Treasury Bond ETF (NASDAQ:TLT) ratio has broken an uptrend, and it will take a drop below 2.95 to confirm the bearish break in trend and what is likely to result in a big outperformance for the TLT relative to the SPY.

SPY vs. TLT Chart

Financials

The Financial Select Sector SPDR® Fund (NYSE:XLF) had a rough week, with the ETF’s rising wedge pattern breaking lower as bond yields fell. The RSI and MACD signal a loss of momentum, with the next level of support coming around $36.60.

Financials (XLF) Daily Chart

Dow Transports

The Dow Jones Transportation also had a bad week, falling below support at 15,340. The next level of support comes at the lower trend line, around 14,690. The RSI and the MACD were suggesting that lower prices are coming for this index.

Dow Transports (DJT) Daily Chart

S&P 500

The S&P 500 broke the rising wedge again on Friday and retested that break at the end of the day. The big question is what’s next. The reason is that the rising wedge is finished, and we need to break one way or the other.

The XLF, as noted already, broke lower from its wedge, as has the housing index. It probably doesn’t speak well for the S&P 500. Monday morning will likely decide what happens next. It would not be surprising to see a reversion to the beginning of the wedge at 4070 over the next couple of weeks.

SP 500 Chart

Intercontinental Exchange

Intercontinental Exchange (NYSE:ICE) doesn’t diverge from the S&P 500 often, and we have to wonder what was happening here. Clearly, ICE was sitting on some key support at $110, and a break of that support isn’t likely to be positive for anyone.

Intercontinental Exchange (ICE) Daily Chart

Apple

Apple (NASDAQ:AAPL) may see a move higher, but it isn’t likely to last long. There was a clear downtrend around a price of $132. Meanwhile, the RSI was also in a clear downtrend, as was the MACD, also suggesting any rally will be short-lived.

Apple (AAPL) Daily Chart

Citigroup

Citigroup (NYSE:C) was in a huge rising wedge pattern, and a break of that uptrend and drop below $75 is likely to send the shares to $69.

Citigroup Daily Chart

ACADIA

ACADIA Pharmaceuticals (NASDAQ:ACAD) moved higher last week following the positive Biogen (NASDAQ:BIIB) FDA approval. It doesn’t mean ACADIA's drug for Dementia-related psychosis has an easier path; it just means there may be hope for something positive when the company finally has that type-A meeting with the FDA.

Maybe ACADIA works out a way to resubmit the sNDA without having to run more trials. At this point, $30 would be really nice, considering how low it got.

Acadia (ACAD) Daily Chart

Original Post

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.